Jia Jie Biomedical Inkomsten in het verleden
Verleden criteriumcontroles 3/6
Jia Jie Biomedical has been growing earnings at an average annual rate of 66.4%, while the Personal Products industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 4% per year. Jia Jie Biomedical's return on equity is 29.7%, and it has net margins of 85.2%.
Belangrijke informatie
66.4%
Groei van de winst
62.6%
Groei van de winst per aandeel
| Personal Products Groei van de industrie | 13.9% |
| Inkomstengroei | 4.0% |
| Rendement op eigen vermogen | 29.7% |
| Nettomarge | 85.2% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Jia Jie Biomedical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 479 | 408 | 149 | 9 |
| 31 Mar 24 | 415 | 180 | 154 | 9 |
| 31 Dec 23 | 333 | 144 | 175 | 9 |
| 30 Sep 23 | 335 | -21 | 165 | 9 |
| 30 Jun 23 | 338 | -38 | 162 | 9 |
| 31 Mar 23 | 320 | -26 | 146 | 9 |
| 31 Dec 22 | 318 | -5 | 121 | 9 |
| 30 Sep 22 | 312 | 7 | 109 | 8 |
| 30 Jun 22 | 283 | 5 | 99 | 8 |
| 31 Mar 22 | 265 | 6 | 90 | 5 |
| 31 Dec 21 | 242 | 5 | 81 | 4 |
| 30 Sep 21 | 238 | -13 | 84 | 2 |
| 30 Jun 21 | 237 | -8 | 86 | 1 |
| 31 Mar 21 | 250 | -32 | 87 | 0 |
| 31 Dec 20 | 270 | -32 | 90 | 0 |
| 30 Sep 20 | 279 | -36 | 92 | 0 |
| 30 Jun 20 | 294 | -43 | 95 | 1 |
| 31 Mar 20 | 327 | -17 | 101 | 1 |
| 31 Dec 19 | 343 | -24 | 107 | 2 |
| 30 Sep 19 | 356 | 30 | 116 | 2 |
| 30 Jun 19 | 384 | 32 | 124 | 2 |
| 31 Mar 19 | 394 | 3 | 138 | 2 |
| 31 Dec 18 | 402 | 2 | 150 | 2 |
| 30 Sep 18 | 446 | -245 | 172 | 2 |
| 30 Jun 18 | 459 | -263 | 190 | 3 |
| 31 Mar 18 | 476 | -246 | 188 | 3 |
| 31 Dec 17 | 522 | -232 | 188 | 3 |
| 30 Sep 17 | 523 | -20 | 174 | 3 |
| 30 Jun 17 | 529 | -6 | 165 | 4 |
| 31 Mar 17 | 577 | 5 | 166 | 8 |
| 31 Dec 16 | 626 | 12 | 174 | 12 |
| 30 Sep 16 | 728 | 21 | 169 | 18 |
| 30 Jun 16 | 802 | 34 | 167 | 25 |
| 31 Mar 16 | 795 | 37 | 169 | 28 |
| 31 Dec 15 | 797 | 38 | 169 | 31 |
| 30 Sep 15 | 712 | 29 | 170 | 29 |
| 30 Jun 15 | 681 | 29 | 171 | 27 |
| 31 Mar 15 | 646 | 27 | 167 | 24 |
| 31 Dec 14 | 589 | 20 | 163 | 21 |
| 30 Sep 14 | 616 | 31 | 174 | 24 |
| 30 Jun 14 | 603 | 32 | 175 | 19 |
| 31 Mar 14 | 595 | 25 | 183 | 16 |
| 31 Dec 13 | 598 | 22 | 180 | 12 |
Kwaliteitswinsten: 4109 has a high level of non-cash earnings.
Groeiende winstmarge: 4109 became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 4109 has become profitable over the past 5 years, growing earnings by 66.4% per year.
Versnelling van de groei: 4109 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: 4109 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (-1%).
Rendement op eigen vermogen
Hoge ROE: 4109's Return on Equity (29.7%) is considered high.